Patent Reports Market Research
A global inventory of Patent Reports, details include Meloxicam, Fipronil, Zoledronic Acid and many more.
first
previous
Title  | Date  | Price |
|---|---|---|
| Irbesartan Pipeline Developer | Mar 2009 | £3,885 |
| Darbepoetin alfa Pipeline Developer | Mar 2009 | £4,425 |
| Rasagiline Pipeline Developer | Mar 2009 | £2,995 |
| Salmeterol Pipeline Developer | Mar 2009 | £2,995 |
| Sertraline Pipeline Developer | Mar 2009 | £2,995 |
| Carprofen (Vet) Pipeline Developer | Mar 2009 | £2,545 |
| Capecitabine Pipeline Developer | Mar 2009 | £2,995 |
| Buprenorphine Pipeline Developer | Mar 2009 | £2,995 |
| Cabergoline Pipeline Developer | Mar 2009 | £2,100 |
| Calcipotriol Pipeline Developer | Mar 2009 | £2,995 |
| Candesartan Pipeline Developer | Mar 2009 | £3,885 |
| Sevelamer Pipeline Developer | Mar 2009 | £2,995 |
| Sildenafil Pipeline Developer | Mar 2009 | £3,440 |
| Tadalafil Pipeline Developer | Mar 2009 | £3,440 |
| Tacrolimus Pipeline Developer | Mar 2009 | £3,440 |
| Roxithromycin Pipeline Developer | Mar 2009 | £2,995 |
| Rosuvastatin Pipeline Developer | Mar 2009 | £3,440 |
| Reboxetine Pipeline Developer | Mar 2009 | £3,440 |
| Sunitinib Pipeline Developer | Mar 2009 | £3,440 |
| Sorafenib Pipeline Developer | Mar 2009 | £3,885 |
| Simvastatin Pipeline Developer | Mar 2009 | £2,545 |
| Sirolimus Pipeline Developer | Mar 2009 | £4,425 |
| Sitagliptin Pipeline Developer | Mar 2009 | £3,885 |
| Solifenacin Pipeline Developer | Mar 2009 | £2,995 |
| Budesonide Pipeline Developer | Mar 2009 | £3,440 |
| Brinzolamide Pipeline Developer | Mar 2009 | £2,995 |
| Ciclosporin Pipeline Developer | Mar 2009 | £3,440 |
| Cetuximab Pipeline Developer | Mar 2009 | £4,425 |
| Ciclosporin (Vet) Pipeline Developer | Mar 2009 | £3,440 |
| Ciprofloxacin Pipeline Developer | Mar 2009 | £3,440 |
| Cisatracurium Pipeline Developer | Mar 2009 | £2,545 |
| Celecoxib Pipeline Developer | Mar 2009 | £3,885 |
| Cefuroxime Pipeline Developer | Mar 2009 | £2,545 |
| Bevacizumab Pipeline Developer | Mar 2009 | £4,425 |
| Bicalutamide Pipeline Developer | Mar 2009 | £2,545 |
| Cefprozil Pipeline Developer | Mar 2009 | £2,545 |
| Ceftiofur (Vet) Pipeline Developer | Mar 2009 | £3,440 |
| Citalopram Pipeline Developer | Mar 2009 | £2,995 |
| Cladribine Pipeline Developer | Mar 2009 | £2,545 |
| Bisoprolol Pipeline Developer | Mar 2009 | £2,545 |
| Bortezomib Pipeline Developer | Mar 2009 | £3,440 |
| Bosentan Pipeline Developer | Mar 2009 | £2,995 |
| Brimonidine Pipeline Developer | Mar 2009 | £2,995 |
| Bimatoprost Pipeline Developer | Mar 2009 | £2,995 |
| Carvedilol Pipeline Developer | Mar 2009 | £2,545 |
| Clarithromycin Pipeline Developer | Mar 2009 | £2,995 |
| Clopidogrel Pipeline Developer | Mar 2009 | £2,995 |
| Cefditoren Pipeline Developer | Mar 2009 | £3,440 |
| Caspofungin Pipeline Developer | Mar 2009 | £3,440 |
| Repaglinide Pipeline Developer | Mar 2009 | £2,995 |
| Riluzole Pipeline Developer | Mar 2009 | £2,545 |
| Tibolone Pipeline Developer | Mar 2009 | £2,100 |
| Thalidomide Pipeline Developer | Mar 2009 | £3,440 |
| Tigecycline Pipeline Developer | Mar 2009 | £3,440 |
| Tiotropium Bromide Pipeline Developer | Mar 2009 | £3,440 |
| Tolterodine Pipeline Developer | Mar 2009 | £2,995 |
| Teriparatide Pipeline Developer | Mar 2009 | £3,885 |
| Terbinafine Pipeline Developer | Mar 2009 | £2,545 |
| Temsirolimus Pipeline Developer | Mar 2009 | £3,885 |
| Temozolomide Pipeline Developer | Mar 2009 | £2,995 |
| Famciclovir Pipeline Developer | Mar 2009 | £2,995 |
| Tenofovir Pipeline Developer | Mar 2009 | £3,885 |
| Topiramate Pipeline Developer | Mar 2009 | £2,995 |
| Zidovudine Pipeline Developer | Mar 2009 | £3,440 |
| Imiquimod Pipeline Developer | Mar 2009 | £3,440 |
| Indapamide Pipeline Developer | Mar 2009 | £2,995 |
| Fludarabine Pipeline Developer | Mar 2009 | £4,735 |
| Finasteride Pipeline Developer | Mar 2009 | £2,545 |
| Fexofenadine Pipeline Developer | Mar 2009 | £2,545 |
| Fipronil (Vet) Pipeline Developer | Mar 2009 | £2,995 |
| Ramipril Pipeline Developer | Mar 2009 | £2,545 |
| Glimepiride Pipeline Developer | Mar 2009 | £2,545 |
| Fluconazole Pipeline Developer | Mar 2009 | £2,100 |
| Florfenicol (Vet) Pipeline Developer | Mar 2009 | £2,545 |
| Trandolapril Pipeline Developer | Mar 2009 | £2,545 |
| Trastuzumab Pipeline Developer | Mar 2009 | £4,425 |
| Ropivacaine Pipeline Developer | Mar 2009 | £2,545 |
| Ropinirole Pipeline Developer | Mar 2009 | £2,995 |
| Rosiglitazone Pipeline Developer | Mar 2009 | £3,885 |
| Tamsulosin Pipeline Developer | Mar 2009 | £2,995 |
| Tazobactam Pipeline Developer | Mar 2009 | £2,545 |
| Rizatriptan Pipeline Developer | Mar 2009 | £3,440 |
| Rivastigmine Pipeline Developer | Mar 2009 | £2,995 |
| Rimonabant Pipeline Developer | Mar 2009 | £3,440 |
| Risedronic Acid Pipeline Developer | Mar 2009 | £2,995 |
| Risperidone Pipeline Developer | Mar 2009 | £2,545 |
| Ritonavir Pipeline Developer | Mar 2009 | £3,885 |
| Travoprost Pipeline Developer | Mar 2009 | £2,995 |
| Valaciclovir Pipeline Developer | Mar 2009 | £3,440 |
| Venlafaxine Pipeline Developer | Mar 2009 | £2,545 |
| Zolazepam (Vet) Pipeline Developer | Mar 2009 | £2,100 |
| Ziprasidone Pipeline Developer | Mar 2009 | £3,885 |
| Voriconazole Pipeline Developer | Mar 2009 | £3,885 |
| Zoledronic Acid Pipeline Developer | Mar 2009 | £3,440 |
| Varenicline Pipeline Developer | Mar 2009 | £2,995 |
| Valganciclovir Pipeline Developer | Mar 2009 | £3,440 |
| Valsartan Pipeline Developer | Mar 2009 | £3,885 |
| Vardenafil Pipeline Developer | Mar 2009 | £3,440 |
| Zolmitriptan Pipeline Developer | Mar 2009 | £2,995 |
| Fesoterodine Pipeline Developer | Mar 2009 | £3,440 |
Filter Results by
Industry Events
2nd International Conference on Drug Discovery and Therapy
01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>
Innovations in Oncology Drug Discovery, Development & Delivery
01 Dec 09 to 01 Dec 09
N/A, UK
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
